Fulvic acid supplements for metabolic syndrome
Official title: Evaluation of Fulvic Acid Supplementation for the Attenuation of Symptoms Associated With Metabolic Syndrome
Run by Arizona State University · NCT07927283 · Data updated 2026-11-12
This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Arizona State University Academic / other |
| Locations | 1 site (Phoenix, Arizona) |
| Status | Recruiting |
| Started | November 6, 2026 |
| Main results expected | November 15, 2027 |
| Study ends | November 15, 2027 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT07927283 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with metabolic syndrome or prediabetes who are not pregnant and are not using multiple obesity, heart disease, thyroid, or cancer medications and who are not current smokers or athletes.
✕Probably not a fit
Patients for whom fulvic acid does not affect their metabolic markers or who do not tolerate the supplement may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study will compare two doses of fulvic acid to placebo over 12 weeks in adults with metabolic syndrome or prediabetes. Participants will receive either 50 mg or 100 mg of fulvic acid daily, or a placebo, to see if the supplement improves metabolic markers and related symptoms. The trial builds on limited prior work and aims to provide controlled data on safety and efficacy in this population. Recruitment is planned at a site in Phoenix, Arizona under the lead sponsorship of Arizona State University. Outcomes will focus on metabolic parameters and markers of metabolic health.
Why it matters
Potential benefit: If successful, participants could experience improvements in metabolic health markers and a possible reduction in risk factors associated with metabolic syndrome.
How similar studies have gone: Limited prior data exist; some nonrandomized studies suggested lipid and antioxidant benefits, but robust randomized evidence is sparse and this trial seeks to provide controlled results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * metabolic syndrome or prediabetes Exclusion Criteria: * pregnant or nursing * multiple medications to treat obesity, heart disease, thyroid conditions, cancer * smokers * competing athletes * vegetarians
Where it's running
-
PBC 850 N 5th Street
Phoenix, Arizona, United States Recruiting
Study contacts
- Study coordinator: Carol Johnston, PhD
- Email: carol.johnston@asu.edu
- Phone: 6024963463
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Low-Calorie Diet in adolescents with Familial Mediterranean Fever and metabolic syndrome
A group of adolescents with both FMF and metabolic syndrome will try a low-calorie diet for 3 months to see if it helps manage metabolic symptoms.
-
Exercise for Metabolic Syndrome and Fatty Liver in Adolescent Girls with Celiac Disease
This study tests whether a 3-month walking program helps improve metabolic syndrome and fatty liver in adolescent females with celiac disease.
-
Longevity Metrics AI/ML Development Study
Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.
-
Cardiorespiratory and muscular fitness in children with obesity and autism
This study tests whether cardiorespiratory fitness and handgrip strength differ between children with obesity who have autism and those who do not, and how these fitness measures relate to body size, composition, and cardiometabolic health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.